APAC

Its expansion is attributed to developments in healthcare infrastructure.

The trade show, which was held in Singapore, successfully brought together over 13,000 visionary digital health innovators, government leaders, and industry pioneers from the medical and healthcare sectors.

There are a total of 93 products in Phase I-III development for PD treatment.

Recruitment and retention pose a major concern for organisations.

It is due to an increased focus on maximising dental chair utilisation.

Its expansion is driven by an ageing population and the rising rates of chronic diseases.

The partnership includes local testing of clinical AI projects developed by Apollo.

This is due to the increasing prevalence of CVD and metabolic disorders.

It is driven by the rising prevalence of these vision conditions.

The Health Care Quality Improvement Programme will be implemented from 2024 to 2028.

More than 150 in vitro diagnostic tests are currently in development.

One key driver is the trend towards new technologies.

Over 40 companies are working on more than 50 therapies for severe asthma.

The project aims to provide services to over 730,000 people.

It is driven by rising diabetes rates.

Smart technologies are gaining traction in the region.